- Home
- PNFP vs CORT Comparison
PNFP vs CORT Comparison
Compare PNFP & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNFP
- CORT
- Stock Information
- Founded
- PNFP 2000
- CORT 1998
- Country
- PNFP United States
- CORT United States
- Employees
- PNFP N/A
- CORT N/A
- Industry
- PNFP Major Banks
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- PNFP Finance
- CORT Health Care
- Exchange
- PNFP Nasdaq
- CORT Nasdaq
- Market Cap
- PNFP 8.3B
- CORT 8.1B
- IPO Year
- PNFP N/A
- CORT N/A
- Fundamental
- Price
- PNFP $104.94
- CORT $71.38
- Analyst Decision
- PNFP Buy
- CORT Strong Buy
- Analyst Count
- PNFP 13
- CORT 4
- Target Price
- PNFP $121.00
- CORT $142.00
- AVG Volume (30 Days)
- PNFP 340.2K
- CORT 1.4M
- Earning Date
- PNFP 07-15-2025
- CORT 07-28-2025
- Dividend Yield
- PNFP 0.91%
- CORT N/A
- EPS Growth
- PNFP N/A
- CORT 8.36
- EPS
- PNFP 6.16
- CORT 1.14
- Revenue
- PNFP $1,668,433,000.00
- CORT $685,446,000.00
- Revenue This Year
- PNFP $27.58
- CORT $35.85
- Revenue Next Year
- PNFP $11.78
- CORT $35.22
- P/E Ratio
- PNFP $16.82
- CORT $62.59
- Revenue Growth
- PNFP 3.47
- CORT 30.93
- 52 Week Low
- PNFP $75.55
- CORT $28.10
- 52 Week High
- PNFP $131.91
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- PNFP 48.53
- CORT 48.38
- Support Level
- PNFP $101.74
- CORT $69.60
- Resistance Level
- PNFP $109.27
- CORT $73.13
- Average True Range (ATR)
- PNFP 2.13
- CORT 3.50
- MACD
- PNFP -0.52
- CORT -0.18
- Stochastic Oscillator
- PNFP 42.50
- CORT 24.77
About PNFP Pinnacle Financial Partners Inc.
Pinnacle Financial Partners Inc is a financial holding company. The company operates through its wholly-owned subsidiary, Pinnacle Bank. The bank provides a full range of lending products, including commercial, real estate, and consumer loans to individuals and small to medium-sized businesses. It operates as a community bank mainly in the urban markets of Nashville, Knoxville, Memphis, and Chattanooga, Tennessee, as well as surrounding counties. It relies heavily on mergers and acquisitions. A majority of its loan portfolio is in commercial loans, mainly real estate, as well as industrial loans. The bank generates a majority of its net revenue through net interest income.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.